# Atara Biotherapeutics, Inc.: Form 8-K, filed Dec 20, 2022

- Company: [Atara Biotherapeutics, Inc.](/companies/atra.md) (CIK 1604464)
- Form: 8-K
- Filed: 2022-12-20
- Accepted by EDGAR: Dec 20, 2022, 16:42 ET
- Period: 2022-12-20
- Accession: 0001193125-22-309181
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1604464/000119312522309181/d392249d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1604464/000119312522309181/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1604464/000119312522309181/d392249d8k.htm

Filed Dec 20, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-309181. Last ingested by Listed: Nov 11, 2026, 02:48 ET. No prices; not investment advice.
